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Indirect measurement of lymphatic absorption in CAPD patients is not
influenced by trapping. The disappearance rate of intraperitoneally
administered macromolecules is often used to calculate lymphatic
absorption during CAPD. The possible contribution of local accumula-
tion (trapping) of such solutes in the tissues surrounding the peritoneal
cavity, leading to overestimation of lymphatic flow, was investigated in
eight CAPD patients. They were studied twice during a four hour dwell,
glucose 1.36%, to which polydisperse neutral dextran 70 1 g/liter had
been added for measurement of lymphatic flow. After the test on day 1
dextran 130 mg/kg was given intravenously and also dextran I glliter
was added to every following dialysis bag until the second test on day
3. This was done to saturate the tissues surrounding the peritoneal
cavity and thereby to create a steady state condition. In one patient the
dextran administration was continued until a third study was done on
day 5. Dextran in serum during day 3 was 1.3 0.5 g/liter (mean SD).
No difference in peritoneal clearance of dextran was found between day
I and day 3(1.11 0.56 versus 0.97 0.41 mi/mm). Also no difference
was found between day 1 (0.32), day 3 (0.62), and day 5 (0.42 mI/mm).
Trapping would have influenced the first but not the second test, as the
second time all tissues were saturated with dextran. As the dextran
absorption rate remained the same, this indicates that trapping is of no
importance and that lymphatic absorption can be measured by the
disappearance of a macromolecular marker.
Fluid can be absorbed from the peritoneal cavity either by
transport across the walls of the peritoneal capillaries (trans-
capillary absorption) or by lymphatic absorption. In experimen-
tal and human studies, the amount of fluid removed by lym-
phatic transport has been quantitated with the use of
macromolecules added to the intraperitoneal fluid [1—4]. When
lymphatic transport is calculated using data on macromolecular
transport, it is assumed that these high molecular weight
substances are transported into the lymphatics without molec-
ular sieving.
The transport of macromolecules from blood to dialysate
through the peritoneal capillaries is size-selectively restricted.
This limitation is caused either by restricted diffusion [5] or by
filtration through pores [6]. The passage of macromolecules
from the peritoneal cavity to blood is considered to be mediated
mainly by lymphatic absorption, and possibly also to a limited
extent by restricted diffusion. Evidence that macromolecules
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are removed by lymphatic absorption is given by the finding
that these substances disappear from the peritoneal cavity
independently of their molecular weight [7] and also appear in
blood at the same time after intraperitoneal administration,
independently of their molecular weight [8—10]. Convective
transcapilary transport from the abdominal cavity to the circu-
lation during a four hour dwell can be neglected for these high
molecular weight solutes [6].
However, controversy exists whether lymphatic absorption
should be calculated using the appearance in blood or the
disappearance from the peritoneal cavity of intraperitoneally
administered macromolecules [11—13]. Calculating the lym-
phatic absorption as the disappearance rate of a macromolecule
yields a considerably higher lymphatic flow rate independent of
the solute used, than calculation of the appearance rate in
plasma. In rats, intraperitoneally administered macromolecules
disappear from the peritoneal cavity at a constant rate [2]. After
a four hour dwell in CAPD patients 15 to 20% of the adminis-
tered quantity is lost [14]. From the disappearance of these
solutes a clearance of macromolecules of about 1.5 ml/min can
be calculated [3, 15, 16]. However, the appearance in the
systemic circulation is only 11 to 20% of the amount lost after a
dwell time of four to eight hours, giving a estimated lymph flow
of about 0.20 mllmin [4, 17]. Only in anesthetized sheep no
discrepancy was found between the appearance and the disap-
pearance of radiolabeled albumin. In that model two out of
three lymphatic pathways from the peritoneal cavity could be
cannulated and were found to be responsible for over 40% of
the amount lost from the peritoneal cavity [18].
In theory, the low appearance rate of a marker into the
circulation could be explained by underestimation of the distri-
bution volume of the marker, or neglecting losses due to
residual renal function. When the recovery of a marker is
correctly estimated, there are two possible explanations for the
differences found between the two methods of calculating
lymphatic absorption. The discrepancy between the two meth-
ods is probably caused by the absence of steady state condi-
tions: the macromolecular marker has been administered during
only one dwell in the previous studies. The first explanation is
that the marker disappears in the tissues surrounding the
peritoneal cavity, followed by local accumulation (trapping).
Then the disappearance rate would overestimate lymphatic
absorption. Such trapping, especially in the anterior abdominal
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wall has been reported in rats by Flessner et a! using radiola-
belied albumin [19, 201. When this mechanism would be impor-
tant in CAPD patients, the disappearance rate of intraperitone-
ally administered macromolecules should decrease after
saturation of these tissues, as can be achieved after repeated
administration. The second explanation for the large difference
between the peritoneal disappearance rate of macromolecules
and the appearance rate in plasma could simply be the slow
passage of these substances through the peritonea! interstitial
tissues before entering the lymphatic vessels or through the
lymphatic system itself, resulting in a delayed appearance in the
circulation. In that case the disappearance rate of intraperito-
neally given macromolecules should not be influenced by
repeated administration. If so, it would imply that lymphatic
absorption can be measured in a reliable way from the disap-
pearance rate of the macromolecular tracer during a single
dialysis dwell.
To elucidate the possible role of trapping during non-steady
state conditions we studied the disappearance of dextran 70
from the peritoneal cavity twice in eight CAPD patients: the
first time in a non-steady state condition using a single gift of
dextran 70 and the second time during steady state conditions
obtained after a single intravenous loading dose of dextran 70
followed by continuous administration of dextran 70 in the
dialysate for two days.
Methods
Patients
Five male and three female CAPD patients were studied
twice with an interval of 48 hours (study 1 on day 1 and study
2 on day 3). One patient was also studied a third time on day 5.
Median age was 42 years (range 27 to 65) and median duration
of CAPD treatment two months (range 1 to 24). The cause of
renal failure in these patients was chronic pyelonephritis in
three, and chronic interstitial nephritis, chronic glomerulone-
phritis, lupus nephritis, diabetic nephropathy and polycystic
disease in one. All patients were treated with four exchanges
per day, five patients using 1.5 liters and three using 2 liters
dialysate. None of the patients had peritonitis during or in the
three weeks before the study.
In addition, six other CAPD patients (5 males, 1 female) were
studied once to investigate whether the disappearance of the
marker used was linear in time (study 3). Median age of these
patients was 69 years (range 56 to 77) and median duration on
CAPD 14 months (range 8 to 39).
Informed consent was obtained from all patients after expla-
nation of the purpose of the study. The protocol was approved
by the medical ethics committee of the University Hospital of
Amsterdam.
Procedure
The studies were done with commercially available pre-
warmed dialysate, glucose concentration 1.36% (Dianeal®,
Baxter B.V., Utrecht, The Netherlands). All exchanges were
performed with the dialysate volume the patients were used to.
The patients were examined twice in the same semi-recumbent
position. Prior to the study the abdominal cavity was rinsed
twice with dialysate that was drained immediately after inflow.
On day 1 20 ml of dextran 1 (Promiten®, NPBI, Emmercom-
pascuum, The Netherlands) was given intravenously before the
test. This was done to minimize the possible occurrence of
anaphylaxis to dextran [211. Then a fresh dialysate bag (test
bag) containing inulin (mutest®, Laevosan-Gesellschaft, Linz/
Donau, Austria) 2.5 glliter and dextran 70 1 glliter (6% dextran
in glucose 5%, Macrodex®, NPBI, Emmercompascuum, The
Netherlands) was instilled for a dwell time of exactly four
hours. After drainage of the test bag the abdominal cavity was
rinsed again with glucose 1.36%. After the test the patients
resumed CAPD on their normal schedule.
Starting with the test bag on day 1 dextran 70 1 g/liter was
added to each dialysate bag up to and including the test bag on
day 3. In one patient dextran was administered intraperitoneally
until the third test on day 5. After drainage of the test bag on
day one, dextran 70, 130 mg per kg body wt, was given
intravenously.
Dialysate samples of the test bag were taken before inflow,
after 10, 20, 30, 60, 120 and 180 minutes and after drainage.
Samples before inflow and after drainage were also obtained
from the rinsing bags. Blood was taken during inflow and four
hours later during outflow of the test bag.
In the other patient group studied once (study 3), the test
procedure was similar to the test on day 1. In contrast to the test
on day 1, dialysate samples between start and end of the test
were always taken after complete drainage of the peritoneal
cavity, followed again by immediate inflow, at 60, 120, and 180
minutes. This study was completed after rinsing the peritoneal
cavity.
Methods
For the measurement of total dextran concentration in the
dialysate 1,25 ml of the sample was mixed with 0.25 ml
trichloroacetic acid (1 g!ml) to precipitate the proteins. It was
then left to incubate at 45°C for one hour to hydrolyze the
inulin. After centrifugation at 3000 rpm for 10 minutes 1.0 ml of
the supernatant was brought on a PD- 10 column (Pharmacia
LKB, Uppsala, Sweden) to obtain further purification. The first
milliliter of eluens (phosphate buffered saline, 0.2% sodium
azide) that came off the column was discarded, but the follow-
ing 3.5 ml were collected and were clean enough for adequate
dextran determination. This was done by high performance
liquid chromatography (HPLC) using a Bio Gel TSK-XL guard
column (40 x 6 mm) from BioRad Chemical Division (Rich-
mond, Virginia, USA) to separate dextran from the matrix. The
column was incorporated in an automated HPLC system con-
taining one HPLC spectroflow 400 pump and a spectroflow 450
controller, both from ABI Kratos Analytical (Ramsey, New
Jersey, USA), a PROMIS sample processor from Spark Hol-
land (Emmen, The Netherlands), an ERMA 7510 refraction
index detector from ERMA (Tokyo, Japan) and an SP 4290
integrator (Spectra Physics, Eindhoven, The Netherlands). The
latter was used in its peak height mode. As a consequence of the
use of the short column as the separating unit, the chromato-
graphic analysis time could be reduced to only seven minutes
for one sample. The coefficient of variation of the method in the
concentration range of 200 mg/liter to 5,000 mg/liter was 2.2%.
To further improve the accuracy all samples were measured in
duplicate.
Urea was measured by use of the DAM-TSC Technicon
SD4-001 DK 7 method, creatinine by the modified Jaffé method
1670 Struijk et a!: Lymphatic absorption and role of trapping
and glucose by the glucose oxidase-peroxidase method, all
determined by autoanalyzers (Technicon SMA and SMA-Il).
The creatinine values obtained in dialysate were corrected
using creatinine measurements in blanks, because of interfer-
ence with the high glucose concentration of the dialysate.
L-Lactate was measured by a lactate dehydrogenase method
(fully enzymated method, no. 149993, Boehringer, Mannheim,
Germany). Inulin was measured by a modification of Walser's
method with the color reagent diphenylamine 1221, selected
because interference with the high glucose concentration of the
dialysate is absent with this method. The coefficient of variation
of the inulin determinations was 4%. To further improve the
accuracy all samples were measured in triplicate. Albumin and
IgG were measured by immunoturbidimetry using commercial
antisera (Dakopatts, Gotrupp, Denmark). The coefficient of
variation of the protein determinations was 2%. Appropriate
control sera were used in each series of measurements.
Calculations
Each experiment was analyzed individually for the determi-
nation of the dextran absorption rate (DAR), peritoneal solute
transport kinetics and net fluid removal. The calculations of
DAR were done using the following equation:
Dex111 — Dex0
DAR (ml/min) =
Dgeomt
Parameters used in this equation are:
Dex1 (in mg). The amount of dextran present at the start of
the test, calculated on day 1 as the amount of dextran instilled.
On day 3 and 5 the residual volume already containing dextran
and therefore Dex10 was calculated as the sum of the amount of
dextran instilled and the amount of dextran present in the
residual volume before inflow.
Dex0 (in mg). The amount of dextran recovered after
drainage, in the residual volume after drainage and in the
samples obtained during the four hour test.
Dgeom (in mg/mi). Geometric mean of the initial (D0) and final
dextran concentration (Di) in the dialysate. D0 is calculated as
Dex of either day 1 or day 3/5, divided by the sum of the
instilled volume and the residual volume before inflow.
t. Time period of the dwell (in minutes). In this approach it is
assumed that DAR is constant during the dialysate dwell time of
the test, as has also been found for the macromolecule albumin
in rats 12]. Furthermore, it is assumed that the disappearance of
dextran from the peritoneal cavity is entirely due to lymphatic
absorption. It is implied that in the study on day 1 the DAR was
overestimated caused by the diffusive solute transport through
the peritoneal membrane from the peritoneal cavity to the
blood. In the study on days 3 and 5 the DAR was either
overestimated or underestimated depending on the concentra-
tion gradient of dextran over the peritoneal membrane. Equa-
tion 1 was corrected for this diffusive transport as follows:
Dex1 — Dex001 — DgeomCdexDay 1: DAR (mllmin) = (2)
in which Cdex is the transcapillary clearance of dextran (in
mi/mm). Assuming symmetry for the diffusional characteristics
of the peritoneal membrane (that is, dialysate to blood or blood
to dialysate), C. was assumed to be 0.05 mllmin. This
represents the mean clearance of dextran 70 from blood to
dialysate, as was calculated for the dextran fraction of so A [51,
because this radius represents the fraction with the highest
concentration [71. The data that are given are corrected for
transcapillary transport of dextran unless stated otherwise. The
standard deviation of the measured DAR, is independent of the
size of the DAR in the range of 0 to 3.0 mllmin, and was
calculated to be 0.25 ml!min [23].
Lymphatic absorption was assumed to be equal to the dex-
tran absorption. The cumulative transcapillary ultrafiltration
(TCUF) at time t, that is, the change of the theoretical intra-
peritoneal volume in the absence of lymphatic absorption, was
calculated as the amount of dextran instilled, divided by the
dextran concentration at time t, minus the intraperitoneal
volume at the start of the test. The difference between TCUF
and lymphatic absorption was considered to represent the
change of the in situ intraperitoneal volume (IPV). TCUF1,
the transcapillary ultrafiltration from 0 to 1 minute, was calcu-
lated by the Lineweaver-Burke plot [15, 16]. The curves in
Figures 2 and 3 of TCUF and IPV were calculated from data
on the various time points using the calculated TCUF by the
method of the Lineweaver-Burke plot.
The residual volume before inflow of the test bag (RV1) was
calculated using equation 4, in which V11 is the volume of the
test bag before inflow, C is the inulin concentration in the test
bag and C is the inulin concentration of the dialysate 10
minutes after inflow of the test bag.
The residual volume after drainage of the test bag (RV2) was
calculated using equation 5, in which Vr, is the volume of the
rinsing bag after the test, Cr10 is
Vinci in
RV I (ml) — V1 (4)
ci,t
the inulin concentration of the rinsing bag after drainage, and
C10,, is the inulin concentration of the test bag after drainage.
Vr1Cr1 OutRV2 (ml) = (5)
— Cr1,0)
Although the residual volumes measured with inulin were used
in calculating DAR, they were also measured using dextran
before inflow of the test bag at day 1.
During study 3 the percentage recovery of dextran was
calculated as Dex0 at the various time points the peritoneal
cavity was completely drained, divided by Dex1 at the start of
the test and multiplied by 100, assuming that the residual
volume was constant during the test. This residual volume was
calculated as RV2.
Mass transfer area coefficients (MTC) for urea (mol wt 60),
lactate (mol wt 90), creatinine (mol wt 113), glucose (mol wt
180) and inulin (mol wt 5,500) were calculated using a mathe-
matical model assuming first order kinetics [24—26]. Protein
clearances for albumin (mol wt 69,000) and IgG (mol wt
150,000) were calculated as the amount of protein drained,
divided by the product of the mean of the determinations of
(3) each protein in serum and the dwell time. Net fluid removal was
Day 3: DAR (mi/mm)
geomt
Dex — Dex0 — (Dgeom — P)Cdex
Dgeomt
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Table 1. Theoretically calculated effect of two days of i.p.
administration of dextran 70 on the dextran concentration within the
peritoneal interstitium and on the dextran disappearance rate into this
interstitial space
Saturation Clearance Clearance Difference
Interstitial Of day 1 day 3 day I and 3
volume interstitium
liters % mi/mm
0.35 99.7 0,3 0.7 0.3 0 0.7
0.5 98.2 0.3 0.7 0.3 0.01 0.699
1 86.7 0.3 0.7 0.3 0.09 0.691
2 63.5 0.3 0.7 0.3 0.25 0.45
calculated by the sum of the difference in weight of the test bag
before inflow and after drainage and the volume of the samples
obtained during the test.
The results are given as mean values 1 standard deviation.
Linear regression analysis was calculated by the method of
least squares. Whether dextran disappeared linear in time
during study 3 was tested using analysis of variance for re-
peated measurements [27]. Differences between the two tests
were analyzed using the Wilcoxon matched-pairs test. A P
value below 0.05 (two-tailed) was considered to indicate a
significant difference.
Theoretical considerations on the volume of the peritoneal
interstitium and the effect of saturation on the disappearance
of dextran
The peritoneal interstitial volume can be calculated as the
product of its peritoneal surface area and thickness. Two
studies are available in which the peritoneal surface area was
measured in six and eight adults. In these studies a mean
peritoneal surface area of 1.04 m2 [281 to 0.78 m2 [291 was
found. To the best of our knowledge, no data are available
regarding an average depth of the peritoneum. In the mesentery
the average thickness from mesothelium to mesothelium is 30
m, with exceptions till 110 m [301. The parietal peritoneum is
loosely attached to the abdominal wall and easily stripped [311,
so the thickness is estimated to be 2 mm. The visceral perito-
neum is more dense and firmly attached to the underlying
tissues [31]. When looking at cross sections of the gut, it seems
that the thickness of the serosa varies from 50 to 250 sm [32].
Using the average contribution of the various parts of the
peritoneum to the total surface area [28, 29], the following
peritoneal interstitial space can be calculated: mesentery and
omentum 30% of 1 m2 x 50 jm = 0.015 liters, viscera 60% of 1
m2 x 150 sm = 0.09 liters and parietal peritoneum 10% of 1 m2
x 2 mm = 0.2 liters, giving a total peritoneal interstitial volume
of about 0.35 liters.
When the disappearance rate of dextran is 1.0 mllmin and it is
assumed that lymph flow is constant at a rate of 0.3 ml, the
transport rate of dextran to the interstitium is 0.7 mi/mm. Then
the dextran concentration in the interstitium after two days of
saturation can be calculated using a simple kinetic model
(equation 6) [25]:
Calculations are based on a four hour dwell, using different interstitial
volumes. At day 1 a dextran clearance of 1 mI/mm is used, consisting of
an assumed lymph flow of 0.3 mI/mm and a dextran disappearance rate
to the interstitium of 0.7 mI/mm. On day 3 the dextran clearance is the
sum of lymph flow and the calculated dextran disappearance rate.
2.5
2.0
I
Dayl Day3
Fig. 1. Lymphatic absorption rate (mi/mm) in eight stable CAPD
patients determined by the disappearance rate of dextran 70 from the
peritoneal cavity before (day 1) and after (day 3) intravenous adminis-
tration of dextran 70 (after correction for dUfusive transport across the
peritoneal capillaries). Also mean values (0) and SD are given.
V /D0—10\
MTC (mi/mm) = — in ( J (6)t
rearranged to equation 7:
— MTC t
I (mg/mi) = D — (D0 — Jo) e v (7)
in which MTC equals the dextran disappearance rate to the
interstitium of 0.7 mi/mm, v is the volume of distribution of the
peritoneal interstitium, I is the initial interstitial concentration,
I the interstitial concentration after two days, D0 the initial
dextran concentration in the dialysate and D the concentration
after two days (both 1 g/iiter).
After two days of saturation the clearance of dextran
(Cdextran) during a four hour dwell can be calculated as follows:
Itv
Cdextran (mi/mm) = — (8)
D0t
in which zI, is the increase in interstitial dextran concentration
from 48 till 52 hours, and t is four hours. The effect of two days
of saturation on the dextran concentration within the peritoneal
interstitiurn and on the clearance of dextran from the peritoneal
cavity, using different pentoneal interstitial volumes and as-
suming a lymph flow of 0.3 mi/mm, is given in Table 1. In the
calculations above, the transport of dextran from blood to
interstitium is neglected. The power of our study to detect a
difference of 0.45 ml was 85% [331.
Results
No differences were found in the calculated DAR between
day 1 and day 3(1.11 0.56 vs. 0.97 0.41 mI/mm, P = 0.23).
The data of the individual patients are shown in Figure 1. In the
patient studied three times the DAR was 0.32 mi/mm on day 1,
0.62 on day 3 and 0.42 on day 5. Probably due to the coefficient
of variation of the calculation of DAR, and perhaps also to the
intrapatient variation, the values in the two tests were not
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Day! Day3
ml
Residual volume0 237 64 256 66
Instilled volume 1751 97 1571 97
TCUF1 6.8 1.8 9.4 2.6
TCUF24Q 347 7! 257 66
LA2 265 48 232 35
Drained volume 1779 148 1711 105
Residual volume240 251 30 314 72
Time, minutes
Fig. 2. The time course of transcapillary ultrafiltration (TCUF) (•),
changes in intraperitoneal volume (LtJPV) (0) and lymphatic absorp-
tion (straight line, calculated as dextran absorption) during the first
study in eight patients. The calculated data points and SEM are given.
The lines of TCUF and IPV are drawn using the Lineweaver-Burke
plot.
always identical. However, values below 0.3 mllmin were never
observed. DAR calculated without correction for transcapillary
transport was also not different between study 1 and study 2
(1.16 0.56 vs. 0.94 0.41 mi/mm, P = 0.11). No differences
were found between the two studies in TCUF and MPV at the
various time points that dialysate was sampled during the test.
The volume parameters in the two studies measured at the start
and the end of the test and the TCUF1 are given in Table 2. The
time course of TCUF, IPV and lymphatic absorption rate
(calculated as DAR) in the two studies is shown in Figures 2 and
3. A linear relationship was found between TCUF and MPV (r
= 0.792, P = 0.00025). No relation was found between lym-
phatic absorption rate (calculated as DAR) and zIPV. No
differences were found in the peritoneal solute transport char-
acteristics between the two studies (Table 3).
The dextran concentrations in serum at the start of the test on
day 3 were 1.3 0.5 g/liter and the end of the test 1.3 0.4
Fig. 3. The time course of transcapillary ultrafiltration (TCUF) (S),
changes in intraperitoneal volume (.JPV) (0) and lymphatic absorp-
tion (straight line, calculated as dextran absorption) during the second
study in eight patients. The calculated data points and SEM are given.
The lines of TCUF and IPV are drawn using the Lineweaver-Burke
plot.
Dayl Day3
mI/mm
Urea 25.4 7,0 24.2 5.6
Lactate 17.1 7.9 16.1 5.8
Creatinine 12.1 4.8 11.6 3.6
Glucose 10.2 3.7 10.3 3.0
Inulin 4.4 1.5 4.6 1.8
Albumin 0.118 0.078 0.103 0.064
IgG 0.068 0.056 0.060 0.036
glliter. Mean dextran concentrations in serum on day 3 ranged
from 648 to 1956 mg/liter, with serum concentrations higher
than 1 g/liter in six of the eight patients. In the patient studied
also on day 5, the dextran concentrations on day 3 and day S
were 795 and 298 mg/liter.
The residual volume is crucial in calculating the amount of
dextran lost during the tests. Therefore we also calculated the
residual volume using the dextran data and compared these
with the residual volume obtained with the use of inulin. No
differences were found between the residual volume calculated
with the use of inulin or dextran before the test of day 1 (237
180 vs. 217 166 ml). A good correlation was found between
the residual volume calculated with the use of inulin or dextran
before the test of day 1 (r = 0.988, P < 0.00001). No significant
correlation was found between the residual volume measured
with inulin before and after the test.
As had been found in rats, study 3 confirmed that the
Table 2. Peritoneal fluid kinetics obtained before (day 1) and after
(day 3) intravenous administration of dextran 70
a)
E
0>
"l
450
300
150
0
—150
—300
Abbreviations are: TCUF, transcapillary ultrafiltration; LA, lym-
phatic absorption (calculated as dextran absorption). The subscripts
represent the dwell time (minutes). Mean values SEM are given. No
significant differences were found between the two days.
450
300
150
E
0> 0
—150
—300
0 60 120 180
Time, minutes
240
0 60 120 180
Table 3. Peritoneal solute transport characteristics obtained before
(day 1) and after (day 3) intravenous administration of dextran 70
240
Mean values SEM are given. Values for urea, lactate, creatinine,
glucose and inulin are calculated as mass transfer area coefficients, for
albumin and IgG as clearances. No significant differences were found
between the two days.
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disappearance of dextran in humans was also linear in time (y
—0.04x + 98, P < 0.0001).
Discussion
In this study no significant differences were found in the
disappearance of intraperitoneally administered dextran 70 in a
non-steady state condition compared to a steady state. The
study is an attempt to demonstrate that lymphatic absorption is
represented by the convective leak of macromolecules from the
peritoneal cavity. If lymphatic absorption is overestimated by
local accumulation, a large difference should have been found
between the two tests. Therefore, this study supports the
concept that lymphatic absorption can be determined as the
disappearance rate from the peritoneal cavity of macromolecu-
lar substances. The order of magnitude of lymphatic absorp-
tion, calculated by the disappearance of dextran, is in the same
order of magnitude as has been found using other markers [3,
151 and as has been found by the comparison of intravenous and
intraperitoneally administered inulin [34].
The assumption that lymphatic absorption is represented by
the disappearance of macromolecules not only includes the
uptake in the subdiaphragmatic lymphatics, but also uptake in
the lymphatic system in all other tissues surrounding the
peritoneal cavity. This assumption is only valid when the
macromolecules enter all lymphatics in the same concentration
as present in the dialysate without size restriction. The pres-
ence of 1251-human serum albumin in the abdominal wall as has
been demonstrated in rats by Flessner et al [19, 20], does not
invalidate the method of calculating lymphatic absorption ac-
cording to Noiph et al [2], provided that the macromolecules in
the abdominal wall eventually enter the circulation by the
lymphatics. Mactier et al using India ink could not confirm the
results of Flessner et al [35].
However, overestimation of lymphatic absorption could oc-
cur under the following conditions. Firstly the marker could
accumulate in the tissues without entering the circulation.
Secondly the marker could accumulate in the tissues in a much
higher concentration than present in the dialysate and thereafter
enter the circulation by diffusion or uptake by the lymphatic
system, while fluid is simultaneously absorbed by the peritoneal
capillaries.
When the first possibility holds true, tissue saturation can be
expected in a steady state after continuous intraperitoneal
administration and a lower disappearance of dextran should
have been found. The second possibility has been suggested by
Flessner et al [12, 201. However, in their studies in rats they did
not observe tissue over dialysate concentration ratios higher
than 1 [20]. The clearances of different fractions of dextran 70
with Einstein-Stokes radii ranging from 35.5 A to 94.8 A from
blood to dialysate, taken from the literature, are 0.02 to 0.1
mi/mm [5]. Therefore very high tissue concentrations of at least
ten- to one hundred-fold the dialysate concentration must be
present before backdiffusion through the capillary walls can
explain the removal of macromolecules from intraperitoneal
tissues. In this situation, diffusion from the interstitium back to
the dialysate compartment should also occur, giving a lower
disappearance of the marker in the second test on day 3.
It is not possible to exclude that a separate uptake of
macromolecules by the interstitial lymphatics is present com-
bined with fluid uptake in the peritoneal capillaries by the
plasma oncotic pressure, when this occurs in the same ratio as
present in the dialysate. Mactier and Khanna have summarized
the data in the literature and concluded that in a short dwell
during CAPD transperitoneal transport of water from dialysate
to blood is not very likely, as a crystalloid osmotic gradient then
is still present at the end of the dwell [361. It implies that during
this period the disappearance of macromolecules will accu-
rately describe the fluid disappearance from the peritoneal
cavity. When more fluid would be resorbed locally than mac-
romolecules by the lymphatics, again a higher tissue concentra-
tion should be present, leading to diffusion to the peritoneal
cavity and a lower disappearance of macromolecules during the
second test.
It could be argued that the time between the two tests was not
long enough for complete tissue saturation. However, this is not
very likely in view of the estimated volume of distribution of the
interstitial space of the peritoneal membrane. In an earlier study
in which dextran 70 was given intravenously, we could demon-
strate the presence of a third compartment, possibly the inter-
stitial space of the peritoneum [5]. This compartment was
saturated after a period of 38 to 46 hours. In the present study
saturation took place for 48 hours both from the circulation and
the peritoneal cavity. In one patient DAR remained the same
even after five days of intraperitoneal administration of dextran.
Theoretically, part of the disappearance from the peritoneal
cavity of dextran could also be explained by either adhesion to
the dialysate bag, or uptake in macrophages within the perito-
neal membrane. The dialysate samples before inflow of the test
bag were taken after the injected dextran was thoroughly mixed
and the bag was heated. Therefore adhesion to the bag will not
have influenced our results. Dextran 40, although structurally
altered, has been found in macrophages in various tissues and
organs, when high dosages of dextran were given repeatedly
[37]. However, the same disappearance rate of dextran 70 was
observed when dextran was given intraperitoneally in a con-
centration ten times as high as in this study [16]. As the capacity
of macrophages in the peritoneal tissues for uptake of dextran
must be limited, a lower disappearance rate should have been
found in that study. It is also not plausible that macrophages are
capable of removing all other macromolecules, that have been
used for volume measurements, in the same percentage of the
total dose administered. Therefore, it is unlikely that uptake of
dextran in peritoneal macrophages is important for the disap-
pearance of intraperitoneal macromolecules. Disappearance
from the circulation of macromolecules, caused by uptake in
liver, spleen and lymph nodes, has been found in dogs using
'4C-dextran [38], and in rats using '251-polyvinylpyrrolidin [39].
Dextrans are slowly oxidized [381, at a rate of about 70 to 90
mg/kg/day [40]. This could probably explain the rather low
serum concentration of dextran in the patient examined on day
5. Removal of macromolecules from the circulation to the
reticuloendothelial cells could also explain the low recovery of
the total amount administered intraperitoneally.
Net ultrafiltration is dependent of both TCUF and lymphatic
absorption rate. However, i.IPV was correlated only with
TCUF. This implies that the lymphatic absorption rate is not
the main determinant of net ultrafiltration during a short dwell,
as has also been suggested by others [411.
A good correlation was found between the residual volume
measurements with either inulin or dextran, indicating that
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inulin can be used to measure residual volume accurately.
Despite standardization of the test procedure, no correlation
was found between the residual volume before and after the
test. This implies that it is essential to measure them both in
order to describe fluid kinetics accurately.
In conclusion, the disappearance of dextran 70 from the
peritoneal cavity in CAPD patients was not influenced by
trapping within the peritoneal interstitial tissues. Therefore, the
disappearance of dextran can be used as an indirect measure-
ment of lymphatic absorption. As the order of magnitude of
lymphatic absorption measured with dextran is in the same
order of magnitude as has been found with other macromolec-
ular markers in CAPD patients, this probably indicates that
fluid from the peritoneal cavity by lymphatic absorption can be
measured accurately by the disappearance of an intraperito-
neally-administered macromolecular marker.
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